Letter of Offer dated July 18, 2026 received from SBI Capital Markets Limited, the manager to the Open Offer appointed by Anupam Rasayan India Limited along with PAC.
M&A
● No Immediate Change
MEDIUM RISK
📅 Filed on BSE: 21 Jul 2026, 07:50 PM IST · BSE ID: 4f7a2fb3-3de8-46e1-a589-2d05f0d3fd88
View Original BSE Filing (PDF)
💡
In Simple Terms
Bliss GVS Pharma has received the official document for Anupam Rasayan India's public offer to buy 26.00% of its shares.
🤖 AI Summary
- Bliss GVS Pharma received the Letter of Offer for a 26.00% open offer from SBI Capital Markets Limited.
- Anupam Rasayan India Limited, along with Mates Visa Consultancy Private Limited (PAC), is the acquirer.
- The open offer is for 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma.
- The offer price for each equity share is ₹ 299.00.
- The acquisition aligns with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Open Offer % of Expanded Voting Share Capital
26.00%
Number of Equity Shares Offered
2,77,26,848
Offer Price per Equity Share
₹ 299.00
🏢 How This Affects the Company
The completion of the open offer could lead to a significant change in the shareholding structure and potentially influence future strategic decisions of Bliss GVS Pharma.
👥 What This Means For Shareholders
✅
Action Required
Eligible public shareholders of Bliss GVS Pharma Limited who wish to tender their shares in the open offer must review the Letter of Offer for specific instructions and timelines.
👤
Who Is Affected
Public shareholders of Bliss GVS Pharma Limited holding up to 2,77,26,848 equity shares are affected, as Anupam Rasayan India Limited is offering to acquire their shares.
🔍
Management Signal
The company's management is facilitating the open offer process by acknowledging receipt of the Letter of Offer, in line with regulatory compliance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Open offer tendering period commencement and closing dates.
Announcement of the final results of the open offer.
Any further regulatory filings related to the acquisition's completion.
MEDIUM RISK
Changes in significant shareholding can impact company control and strategic direction.
💡 Investor Takeaway
Bliss GVS Pharma Ltd. received the Letter of Offer for Anupam Rasayan India Limited's open offer to acquire 26.00% of its expanded voting share capital. The offer is for 2,77,26,848 equity shares at ₹ 299.00 per equity share, in compliance with SEBI (SAST) Regulations.
📅 Company Track Record
Previous filings indicated Bliss GVS Pharma received a Draft Letter of Offer on June 9, 2026, for a 26.00% open offer by Anupam Rasayan India Limited at ₹ 299.00 per share, following the initial offer announcement on June 1, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the key update regarding the open offer for Bliss GVS Pharma shares?
Bliss GVS Pharma Limited has received the Letter of Offer dated July 18, 2026, from SBI Capital Markets Limited, for an open offer by Anupam Rasayan India Limited along with PAC.
What percentage of Bliss GVS Pharma's capital is targeted in this open offer?
The open offer targets up to 26.00% of Bliss GVS Pharma Limited's Expanded Voting Share Capital.
What is the offer price for each equity share in the Bliss GVS Pharma open offer?
The offer price is ₹ 299.00 (Indian Rupees Two Hundred Ninety-Nine Only) per equity share.
How many equity shares are being acquired through this open offer for Bliss GVS Pharma?
The open offer is for the acquisition of up to 2,77,26,848 (Two Crore Seventy-Seven Lakh Twenty-Six Thousand Eight Hundred Forty-Eight) fully paid-up equity shares.
Questions based on this BSE filing only. For information purposes.